Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Investment Summary

Market Valuation
Undervalued
Consensus
Playing (BUY)
Best For
Income Growth

How This Company Makes Money

Dividend Snapshot NOVO-B

Aristocrat - 25 or more consecutive years of dividend increases

Max Ratio

18.82

Dividend Yield

4.05 %

5Y Dividend Growth

156.00 %

Consecutive Years

31 year

5Y Average Payout Ratio

59.95 %

Dividend History NOVO-B

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 4.05 %
Consecutive Years 31
Forward Annual Dividend 11.70 DKK
Consistent Years 33
Dividend CAGR 3Y 23.40 %
Continuous Dividends 34
Dividend CAGR 5Y 20.69 %
Payout Ratio TTM 29.45 %
Dividend CAGR 10Y 13.79 %
Ex Dividend Date 08/14/2026

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Business Quality Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

MaxDividends Quality Score

Business Quality Score
Dividend Score

Sales Growth NOVO-B

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin NOVO-B

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income NOVO-B

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM NOVO-B

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio NOVO-B

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Novo Nordisk A/S NOVO-B

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself NOVO-B

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 11.04
Forward PE 14.12
Enterprise Value Revenue 4.30
Price Sales TTM 3.89
Enterprise Value EBITDA 9.58
Price Book MRQ 5.97

Bottom Line

Novo Nordisk A/S

NOVO-B
Current price
288.90 DKK -1.1 DKK (-0.38%)
Last closed 292.00 DKK
ISIN DK0062498333
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Copenhagen Exchange
Capitalization 1 285 462 901 130 DKK
Yield for 12 month -16.48 %
1Y
3Y
5Y
10Y
15Y
NOVO-B
11/21/2021 - 11/28/2021

Advanced Highlights

Current Year

+310 183 009 886 DKK

Last Year

+291 454 445 098 DKK

Current Quarter

+78 772 176 897 DKK

Last Quarter

+97 173 561 351 DKK

Current Year

+251 182 159 623 DKK

Last Year

+246 771 246 906 DKK

Current Quarter

+61 610 263 927 DKK

Last Quarter

+83 526 327 873 DKK
EBITDA 174 305 824 883 DKK
Operating Margin TTM 42.54 %
Price to Earnings 11.04
Return On Assets TTM 18.73 %
PEG Ratio 3.28
Return On Equity TTM 59.82 %
Wall Street Target Price 1 992.32 DKK
Revenue TTM 330 623 742 299 DKK
Book Value 50.15 DKK
Revenue Per Share TTM 74.45 DKK
Dividend Share 11.74 DKK
Quarterly Revenue Growth YOY 2.10 %
Dividend Yield 4.05 %
Gross Profit TTM 271 069 899 313 DKK
Earnings Per Share 26.35 DKK
Diluted EPS TTM 26.35 DKK
Most Recent Quarter II 2026
Quarterly Earnings Growth YOY -20.60 %
Profit Margin 35.35 %
Price to Free Cash Flow TTM 19.75

Technical Indicators NOVO-B

For 52 Weeks

214.82 DKK 392.72 DKK
50 Day MA 312.84 DKK
Shares Short Prior Month
200 Day MA 299.91 DKK
Short Ratio
Shares Short
Short Percent